Now showing items 1-2 of 2
Advances in a C. elegans model of Alzheimer's disease for drug screening against neurodegeneration
Alzheimer’s disease (AD) is the sixth leading cause of death in the United States, yet no treatment effectively prevents, halts or reverses the disease. Progress in developing treatments is hampered by the extensive time ...
A century of questions: Retrospective study of the controversy and efficacy of Alzheimer's disease models
Alzheimer’s disease (AD) has been a devastating challenge to the research, medical, and public community for more than a century. In 1906, Alois Alzheimer characterized it as a neurodegenerative disease associated with ...